Oregano oil, a concentrated plant oil sold as a supplement, is promoted for gut infections, bacterial overgrowth and respiratory complaints. Human evidence is thin: small, short studies, mostly of related products. Risks are mostly mild irritation; cell studies suggest it may speed the breakdown of many medications, and its history in mixtures used to end pregnancies is a concern. It is a plausible short-course tool, not a daily longevity supplement. (Full Review)

Protocol

Emulsified oil (integrative approach)

600 mg/day

for 6 weeks in the parasite study

Carvacrol-standardized dosing

123 mg carvacrol/day

for 15 days, then 62 mg for 30 days, split twice daily

Time of day

With meals

for tolerance; sources differ; morning and midday dosing avoid evening heartburn

Time to effect

Gut infection courses

4–6 weeks

length of bacterial overgrowth and parasite courses

Lung function

1–2 months

changes with carvacrol

Gut symptoms

Within 10 days

eased in an H. pylori series using an oil blend including oregano

Benefits

Low: Blood lipids, gastrointestinal infections, surgical wound contamination, airway symptoms and lung function, upper respiratory symptom relief, bacterial vaginosis

Speculative: Antifungal activity, anticancer activity, neuroprotection, oxidative stress and exercise muscle damage

Contraindications

Pregnancy and breastfeeding

Known allergy to mint-family herbs (thyme, sage, mint, basil)

Organ-transplant recipients on tacrolimus or cyclosporine

Scheduled surgery within 2 weeks or bleeding disorders

Young children (undiluted essential oil)

Key Interactions

Iron supplements (ferrous sulfate, iron bisglycinate) and dietary iron

Warfarin-type anticoagulants (warfarin, acenocoumarol)

Theoretical (inferred from mechanism)

CYP3A4 substrates (midazolam, oral contraceptives, simvastatin)

CYP1A2 substrates (theophylline, clozapine)

Direct oral anticoagulants (apixaban, rivaroxaban) and antiplatelet drugs (clopidogrel, aspirin)

Glucose-lowering drugs (metformin, sulfonylureas, insulin)

Lithium

Over-the-counter drugs (omeprazole, ibuprofen)

Supplements with additive effects (fish oil, ginkgo, berberine, St. John's wort)

Probiotics and other antimicrobial herbs (thyme oil, allicin)

Risk & Side Effects

Low: Gastrointestinal irritation, mucosal and skin irritation, allergic reactions, pregnancy loss, liver injury, red-cell and iron shifts, bleeding tendency

Speculative: Drug interactions via enzyme induction, white-cell suppression

Monitoring

Marker	Target	Why
Hemoglobin	Men 13.5–17.5 g/dL; women 12.0–15.5 g/dL	Safety check: red-cell decreases
Ferritin	Men 24–336 ng/mL; women 11–307 ng/mL	Safety check: iron decreases
Serum iron	Not specified in the ER	Paired with ferritin
LDL cholesterol	No established target; track change from own baseline	Lipid signal
HDL cholesterol	No established target; track change from own baseline	HDL rise
Lactulose breath test	No established target; track whether a positive test turns negative	Bacterial overgrowth response
Stool parasite test	No established target; track whether a positive test turns negative	Parasite response
INR (warfarin-type anticoagulant users only)	No established target for this interaction; track change from own stable INR	Safety check: INR rise
Drug level (narrow-margin CYP3A4- or CYP1A2-cleared drugs)	Not specified in the ER	Safety check: faster drug breakdown

Cadence: baseline tests before starting; symptom check at 2 weeks; target problem retested 4–6 weeks after the course ends; blood count and ferritin repeated at the end of any course longer than 4 weeks; drug levels or INR rechecked 1–2 weeks after starting and again after stopping

Qualitative Assessment

Digestive comfort: bloating, gas, stool form and abdominal pain
Heartburn or "heated sensation" after doses
Respiratory symptoms: cough, wheeze, sore throat
Skin reactions at application sites, or hives
Energy and exercise recovery

Oregano Oil for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment